These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15953495)

  • 21. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study.
    Schrepf A; Harper DE; Harte SE; Wang H; Ichesco E; Hampson JP; Zubieta JK; Clauw DJ; Harris RE
    Pain; 2016 Oct; 157(10):2217-2225. PubMed ID: 27420606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.
    Tuominen L; Nummenmaa L; Keltikangas-Järvinen L; Raitakari O; Hietala J
    Hum Brain Mapp; 2014 May; 35(5):1875-84. PubMed ID: 23671038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.
    Mick I; Myers J; Ramos AC; Stokes PR; Erritzoe D; Colasanti A; Gunn RN; Rabiner EA; Searle GE; Waldman AD; Parkin MC; Brailsford AD; Galduróz JC; Bowden-Jones H; Clark L; Nutt DJ; Lingford-Hughes AR
    Neuropsychopharmacology; 2016 Jun; 41(7):1742-50. PubMed ID: 26552847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.
    Karjalainen T; Tuominen L; Manninen S; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L
    Soc Cogn Affect Neurosci; 2016 Aug; 11(8):1310-6. PubMed ID: 27053768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
    Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
    Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. μ-opioid receptor system mediates reward processing in humans.
    Nummenmaa L; Saanijoki T; Tuominen L; Hirvonen J; Tuulari JJ; Nuutila P; Kalliokoski K
    Nat Commun; 2018 Apr; 9(1):1500. PubMed ID: 29662095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF
    PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans.
    Burghardt PR; Rothberg AE; Dykhuis KE; Burant CF; Zubieta JK
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3193-201. PubMed ID: 26108093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge.
    Scott DJ; Stohler CS; Koeppe RA; Zubieta JK
    Synapse; 2007 Sep; 61(9):707-14. PubMed ID: 17559096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain.
    Schroeder JA; Niculescu M; Unterwald EM
    Synapse; 2003 Jan; 47(1):26-32. PubMed ID: 12422370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.
    Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J
    Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices.
    Greenwald M; Johanson CE; Bueller J; Chang Y; Moody DE; Kilbourn M; Koeppe R; Zubieta JK
    Biol Psychiatry; 2007 Jan; 61(1):101-10. PubMed ID: 16950210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [11C]Carfentanil Binds Preferentially to μ-Opioid Receptor Subtype 1 Compared to Subtype 2.
    Eriksson O; Antoni G
    Mol Imaging; 2015; 14():476-83. PubMed ID: 26461068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain.
    Joutsa J; Karlsson HK; Majuri J; Nuutila P; Helin S; Kaasinen V; Nummenmaa L
    Psychiatry Res Neuroimaging; 2018 Jun; 276():41-45. PubMed ID: 29655552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced mu opioid receptor availability in schizophrenia revealed with [
    Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD
    Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects.
    Hirvonen J; Aalto S; Hagelberg N; Maksimow A; Ingman K; Oikonen V; Virkkala J; Någren K; Scheinin H
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):275-86. PubMed ID: 18779961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult attachment style is associated with cerebral μ-opioid receptor availability in humans.
    Nummenmaa L; Manninen S; Tuominen L; Hirvonen J; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Dunbar RI; Sams M
    Hum Brain Mapp; 2015 Sep; 36(9):3621-8. PubMed ID: 26046928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interindividual variability and lateralization of μ-opioid receptors in the human brain.
    Kantonen T; Karjalainen T; Isojärvi J; Nuutila P; Tuisku J; Rinne J; Hietala J; Kaasinen V; Kalliokoski K; Scheinin H; Hirvonen J; Vehtari A; Nummenmaa L
    Neuroimage; 2020 Aug; 217():116922. PubMed ID: 32407992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placebo effects on human mu-opioid activity during pain.
    Wager TD; Scott DJ; Zubieta JK
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.